Cannabis In Science & Health

The University of California in Los Angeles (UCLA) is set to create a rooftop garden designed for psychedelic-assisted therapy sessions, according to a report from UCLA Health. This innovative proposal aims to transform the eighth floor of the university’s Semel Institute for Neuroscience and Human Behavior into a “living laboratory,” says Dr. Helena Hansen, MD, […]

The Oklahoma Court of Criminal Appeals ruled that women with state-issued medical cannabis cards who consume cannabis while pregnant cannot be prosecuted for child neglect, The Frontier reports. The landmark decision came in the case of Amanda Aguilar, who faced felony child neglect charges in 2020 after her son tested positive for cannabis at birth.

A recent study by researchers at Washington University School of Medicine in St. Louis has found a link between cannabis use and an increased risk of severe illness related to COVID-19, reports NeuroscienceNews.com. Published on June 21 in JAMA Network Open, the study analyzed medical records of 72,501 patients treated for COVID-19 at health clinics

Three pharmaceutical companies in Zimbabwe have started manufacturing cannabis medicines, according to SABC News. This development comes five years after the Medicines Control Association of Zimbabwe licensed 60 cannabis farmers. Zimbabwe’s Finance Minister, Mthuli Ncube, anticipates the cannabis market could generate $1 billion, potentially outpacing tobacco, currently the country’s top agricultural export, as reported by

Connecticut’s Medical Marijuana Program Board of Physicians has unanimously approved the addition of female orgasmic disorder (FOD) as a qualifying condition for medical cannabis treatment. This marks a significant step forward in addressing a condition that affects up to 41 percent of women, who experience delayed, infrequent, or absent orgasms. The decision was influenced by

Rhode Island is stepping into the forefront of cannabis education with the launch of a groundbreaking training program aimed at preparing workers for careers in the burgeoning cannabis industry. The initiative, announced on May 29, will be funded by Rhode Island’s Department of Labor and Training through its Real Jobs RI initiative. Partnering with the

A study published in the journal Pain suggests that cannabis terpenes—the compounds responsible for the aroma and taste of plants—provide an alternative for relieving chemotherapy-induced neuropathic pain without any side effects. The research found that terpenes were as effective as morphine in reducing chronic neuropathic pain. Additionally, combining terpenes with morphine enhanced pain relief without

A recent study, published in the journal Social Psychological and Personality Science and reported by U of T News, sheds light on the common stereotype surrounding cannabis users. Contrary to popular belief, the study suggests that regular cannabis consumers are not necessarily lazy or unmotivated. Led by Prof. Michael Inzlicht from the University of Toronto,

The 2024 Vangst Jobs Report, produced in collaboration with Whitney Economics, reveals promising trends in the U.S. cannabis industry’s employment landscape. According to the report, the sector now boasts 440,445 “full-time equivalent jobs,” marking a notable 5.4% increase from the previous year. Moreover, the industry witnessed the addition of 22,952 new jobs in 2023, signaling